Department of Chemistry, Biotechnology and Chemical Engineering, Graduate School of Science and Engineering, Kagoshima University, Kagoshima, Kagoshima, Japan.
MAbs. 2009 Sep-Oct;1(5):453-61. doi: 10.4161/mabs.1.5.9633. Epub 2009 Sep 26.
A costimulatory signal is required for the full activation of T cells, in addition to the antigen-specific signal via the T cell receptor. The inducible costimulator, ICOS is one of the costimulatory molecules that play an essential role in this process, particularly in the expansion or the development of effector T cells. As blocking of the interaction between ICOS and its ligand, B7RP-1, suppresses the T cell response, it can be applied to the treatment of allograft rejection or autoimmune diseases. Here, we isolated four scFv clones that were specific to human B7RP-1 by biopanning a human antibody phage library. We found that three of these clones inhibited the interaction between ICOS-Fc and B7RP-1-Fc. These inhibitory clones not only recognized B7RP-1 molecules expressed on B cells, as assessed by FACS, but also exhibited inhibitory activity in a proliferation assay of T cells stimulated with anti-CD3 mAb and B7RP-1-Fc. Finally, the suppression effect of the scFv on the allogenic immune response was examined using a mixed lymphocyte reaction assay, which demonstrated a successful inhibition of the allogenic reaction, in spite of the high dose needed for complete inhibition (360 nM).
除了 T 细胞受体的抗原特异性信号外,共刺激信号对于 T 细胞的完全激活也是必需的。诱导共刺激分子 ICOS 是在该过程中发挥重要作用的共刺激分子之一,特别是在效应 T 细胞的扩增或发育中。由于阻断 ICOS 与其配体 B7RP-1 之间的相互作用会抑制 T 细胞反应,因此它可用于治疗移植物排斥反应或自身免疫性疾病。在这里,我们通过对人抗体噬菌体文库进行生物淘选,分离出了四个针对人 B7RP-1 的 scFv 克隆。我们发现,其中三个克隆可抑制 ICOS-Fc 与 B7RP-1-Fc 的相互作用。这些抑制性克隆不仅通过流式细胞术评估识别 B 细胞上表达的 B7RP-1 分子,而且在抗 CD3 mAb 和 B7RP-1-Fc 刺激的 T 细胞增殖测定中表现出抑制活性。最后,通过混合淋巴细胞反应测定检查了 scFv 对同种异体免疫反应的抑制作用,尽管完全抑制所需的剂量很高(360 nM),但该测定显示出成功的抑制同种异体反应。